Large-Scale Prediction of Drug-Target Interaction: a Data-Centric Review
暂无分享,去创建一个
[1] Chee Keong Kwoh,et al. Drug-target interaction prediction via class imbalance-aware ensemble learning , 2016, BMC Bioinformatics.
[2] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[3] Yanli Wang,et al. PubChem BioAssay: 2017 update , 2016, Nucleic Acids Res..
[4] George Hripcsak,et al. Computational Drug Target Screening through Protein Interaction Profiles , 2016, Scientific Reports.
[5] L. Siu,et al. Approaches to modernize the combination drug development paradigm , 2016, Genome Medicine.
[6] V. Narayan,et al. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders , 2016, BMC Pharmacology and Toxicology.
[7] Antje Chang,et al. BRENDA in 2017: new perspectives and new tools in BRENDA , 2016, Nucleic Acids Res..
[8] Yi Pan,et al. Predicting drug-target interaction using positive-unlabeled learning , 2016, Neurocomputing.
[9] S. Bhanumathi,et al. Generating Drug-Gene Association for Vibrio Cholerae using Ontological Profile Similarity , 2016 .
[10] B. Schmidt,et al. Parallel algorithms for large-scale biological sequence alignment on Xeon-Phi based clusters , 2016, BMC Bioinformatics.
[11] George Hripcsak,et al. Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations , 2016, Journal of Cheminformatics.
[12] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..
[13] Thomas C. Wiegers,et al. Advancing Exposure Science through Chemical Data Curation and Integration in the Comparative Toxicogenomics Database , 2016, Environmental health perspectives.
[14] Zheng Yin,et al. Improving chemical similarity ensemble approach in target prediction , 2016, Journal of Cheminformatics.
[15] Bin Chen,et al. Predicting drug target interactions using meta-path-based semantic network analysis , 2016, BMC Bioinformatics.
[16] Arzucan Özgür,et al. A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction , 2016, BMC Bioinformatics.
[17] Erik Schultes,et al. The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.
[18] Sahand Khakabimamaghani,et al. Drug-target interaction prediction from PSSM based evolutionary information. , 2016, Journal of pharmacological and toxicological methods.
[19] Tudor I. Oprea,et al. ChemProt-3.0: a global chemical biology diseases mapping , 2016, Database J. Biol. Databases Curation.
[20] Ivan G. Costa,et al. A multiple kernel learning algorithm for drug-target interaction prediction , 2016, BMC Bioinformatics.
[21] Anne Mai Wassermann,et al. Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository , 2016, J. Chem. Inf. Model..
[22] Pierre Baldi,et al. Accurate and efficient target prediction using a potency-sensitive influence-relevance voter , 2015, Journal of Cheminformatics.
[23] Yoshihiro Yamanishi,et al. Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner , 2015, BMC Medical Genomics.
[24] Feng Xu,et al. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information , 2015, Nucleic Acids Res..
[25] Yanli Wang,et al. In Silico Study of Polypharmacology with Ligand-based Interaction Fingerprint , 2015 .
[26] Peer Bork,et al. The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..
[27] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[28] Joanna L. Sharman,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..
[29] Tao Wang,et al. Quantitative structure–activity relationship: promising advances in drug discovery platforms , 2015, Expert opinion on drug discovery.
[30] Yan Li,et al. An eigenvalue transformation technique for predicting drug-target interaction , 2015, Scientific Reports.
[31] Yan Li,et al. Large-scale Direct Targeting for Drug Repositioning and Discovery , 2015, Scientific Reports.
[32] J. Guan,et al. Improving compound-protein interaction prediction by building up highly credible negative samples. , 2015, Bioinformatics.
[33] Xing-Ming Zhao,et al. A Survey on the Computational Approaches to Identify Drug Targets in the Postgenomic Era , 2015, BioMed research international.
[34] Cui Tao,et al. Colorectal cancer drug target prediction using ontology-based inference and network analysis , 2015, Database J. Biol. Databases Curation.
[35] Jie Li,et al. PDB-wide collection of binding data: current status of the PDBbind database , 2015, Bioinform..
[36] Fei Luo,et al. Predicting target-ligand interactions using protein ligand-binding site and ligand substructures , 2015, BMC Systems Biology.
[37] Yoshihiro Yamanishi,et al. Benchmarking a Wide Range of Chemical Descriptors for Drug‐Target Interaction Prediction Using a Chemogenomic Approach , 2014, Molecular informatics.
[38] Richard D. Smith,et al. Recent improvements to Binding MOAD: a resource for protein–ligand binding affinities and structures , 2014, Nucleic Acids Res..
[39] Siu-Ming Yiu,et al. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering1 , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[40] Loris Nanni,et al. A set of descriptors for identifying the protein-drug interaction in cellular networking. , 2014, Journal of theoretical biology.
[41] Guillermo Palma,et al. Drug-Target Interaction Prediction Using Semantic Similarity and Edge Partitioning , 2014, SEMWEB.
[42] Hao Ding,et al. Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..
[43] Ali Masoudi-Nejad,et al. Drug–target interaction prediction via chemogenomic space: learning-based methods , 2014, Expert opinion on drug metabolism & toxicology.
[44] Xian Liu,et al. In Silico target fishing: addressing a “Big Data” problem by ligand-based similarity rankings with data fusion , 2014, Journal of Cheminformatics.
[45] Mathias Dunkel,et al. SuperPred: update on drug classification and target prediction , 2014, Nucleic Acids Res..
[46] Yoshihiro Yamanishi,et al. DINIES: drug–target interaction network inference engine based on supervised analysis , 2014, Nucleic Acids Res..
[47] Tapio Pahikkala,et al. Toward more realistic drug^target interaction predictions , 2014 .
[48] S. Jaeger,et al. Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer , 2014, Journal of biomolecular screening.
[49] Dachuan Zhang,et al. MMDB and VAST+: tracking structural similarities between macromolecular complexes , 2013, Nucleic Acids Res..
[50] Yong Wang,et al. Computational Study of Drugs by Integrating Omics Data with Kernel Methods , 2013, Molecular informatics.
[51] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[52] Damian Szklarczyk,et al. STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..
[53] Hyunju Lee,et al. Predicting Drug-Target Interactions Using Drug-Drug Interactions , 2013, PloS one.
[54] Yang Jiang,et al. Prediction of Drugs Target Groups Based on ChEBI Ontology , 2013, BioMed research international.
[55] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[56] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[57] Yanli Wang,et al. PubChem BioAssay: 2014 update , 2013, Nucleic Acids Res..
[58] Nobuyoshi Sugaya,et al. Training Based on Ligand Efficiency Improves Prediction of Bioactivities of Ligands and Drug Target Proteins in a Machine Learning Approach , 2013, J. Chem. Inf. Model..
[59] Louiqa Raschid,et al. Drug-target interaction prediction for drug repurposing with probabilistic similarity logic , 2013, BioKDD '13.
[60] Xiaofeng Liu,et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..
[61] Yuhao Wang,et al. Predicting drug-target interactions using restricted Boltzmann machines , 2013, Bioinform..
[62] Hailin Chen,et al. A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks , 2013, PloS one.
[63] J. Medina-Franco,et al. Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.
[64] Jie Li,et al. Prediction of Polypharmacological Profiles of Drugs by the Integration of Chemical, Side Effect, and Therapeutic Space , 2013, J. Chem. Inf. Model..
[65] Jie Shen,et al. Adverse Drug Events: Database Construction and in Silico Prediction , 2013, J. Chem. Inf. Model..
[66] Yoshihiro Yamanishi,et al. Drug target prediction using adverse event report systems: a pharmacogenomic approach , 2012, Bioinform..
[67] Yoshihiro Yamanishi,et al. Relating drug–protein interaction network with drug side effects , 2012, Bioinform..
[68] Bin Chen,et al. Assessing Drug Target Association Using Semantic Linked Data , 2012, PLoS Comput. Biol..
[69] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[70] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[71] S. Bryant,et al. Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review , 2012, The AAPS Journal.
[72] Anders Wallqvist,et al. Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach , 2012, J. Chem. Inf. Model..
[73] Evan Bolton,et al. PubChem's BioAssay Database , 2011, Nucleic Acids Res..
[74] Philip E. Bourne,et al. SuperTarget goes quantitative: update on drug–target interactions , 2011, Nucleic Acids Res..
[75] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[76] Yanli Wang,et al. Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining , 2011, J. Chem. Inf. Model..
[77] Didier Rognan,et al. Enhancing the Accuracy of Chemogenomic Models with a Three-Dimensional Binding Site Kernel , 2011, J. Chem. Inf. Model..
[78] Ruili Huang,et al. The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics , 2011, Science Translational Medicine.
[79] Philip E. Bourne,et al. PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..
[80] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[81] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[82] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[83] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[84] Xueqin Xu,et al. A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails , 2007, BMC Medical Genetics.
[85] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[86] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[87] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[88] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[89] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[90] Hiroshi Mamitsuka,et al. A probabilistic model for mining implicit 'chemical compound-gene' relations from literature , 2005, ECCB/JBI.
[91] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[92] B. Roth,et al. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .
[93] Zhiyong Lu,et al. A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..
[94] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..